Who owns MANGOCEUTICALS INC COM NEW?
- Ticker: MGRX
- CUSIP Number: 56270v205
Tip: Access positions for across all investors
Analyze quarterly positions in Mangoceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Mangoceuticals stock
Who bought or sold MANGOCEUTICALS INC COM NEW this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Vanguard Group | 192k | $421k | 5% | Sep 2025 |
|
| Geode Capital Management | 88k | $193k | 232% | Sep 2025 |
|
| Ackerman Capital Advisors | 35k | $76k | 0% | Sep 2025 |
|
| XTX Topco | 29k | $62k | 100% | Sep 2025 |
|
| Northern Trust | 19k | $42k | 100% | Sep 2025 |
|
| Sunbelt Securities | 7.0k | $15k | 100% | Sep 2025 |
|
| Advisor Group Holdings | 2.9k | $6.1k | 0% | Sep 2025 |
|
| Steward Partners Investment Advisory | 2.1k | $4.6k | 0% | Sep 2025 |
|
| Royal Bank of Canada | 451.00 | $1.0k | 100% | Sep 2025 |
|
| UBS Group | 3.00 | $6.999900 | -96% | Sep 2025 |
|
Who sold out of Mangoceuticals?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Renaissance Technologies | Jun 2025 | 31k | $47k |
| Tower Research Capital | Jun 2025 | 1.9k | $2.8k |